A research team from Karolinska Institute (KI) and Royal Insitute of Technology (KTH) have developed a drug involving thernostic nanoparticles. These particles carry drugs to a cancer site. They have been altered to be visible during an MR scan.
This is exciting news considering medical professionals will be able to track the drug as it moves through the body.
“For this study, we produced theranostic nanoparticles able to make pinpoint deliveries of drug payloads to breast cancer cells,” says Eva Malmstrom of the School of Chemical Science and Engineering at KTH. “They are also detectable in an MR scanner and can therefore be used diagnostically. The building blocks that we use are biodegradable and show no signs of toxicity.”
This is exciting news considering medical professionals will be able to track the drug as it moves through the body.
“For this study, we produced theranostic nanoparticles able to make pinpoint deliveries of drug payloads to breast cancer cells,” says Eva Malmstrom of the School of Chemical Science and Engineering at KTH. “They are also detectable in an MR scanner and can therefore be used diagnostically. The building blocks that we use are biodegradable and show no signs of toxicity.”
So far, the drug used treats cancer of the bladder, lung, breast and ovaries. The next step will be to tailor the drug to target brain tumors.
For the full article, visit http://www.aalatimes.com/2013/03/02/trackable-drug-filled-nanoparticles-a-potential-weapon-against-cancer/.
For the full article, visit http://www.aalatimes.com/2013/03/02/trackable-drug-filled-nanoparticles-a-potential-weapon-against-cancer/.
No comments:
Post a Comment